Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8650992 | American Heart Journal | 2018 | 7 Pages |
Abstract
Our findings demonstrate contemporary troponin testing is largely nonselective (77% of testing was performed in patients without acute coronary syndrome). In comparison to patients with acute coronary syndrome, those with non-acute coronary syndrome are older, with longer hospital stay, lower revascularization rates, and greater 1-year mortality. Troponin elevation identifies a high-risk population in both acute coronary syndrome and non-acute coronary syndrome populations, yet effective treatment for the latter is lacking.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Alex R. MD, Alexander J. BS, David M. MD, Craig E. MD, Ross F. MS, Matthew F. BA, Timothy D. MD, Scott W. MD,